BioNexus Gene Lab Corp Common stock (BGLC) had the best year between 2021 and 2023 by a US stock in 2021, returning 11,112,943.5%.

ASSET	YEAR	% RETURN
BioNexus Gene Lab Corp Common stock (BGLC)	2021	11,112,943.48%
Azitra (AZTR)	2023	492,757.14%
MDxHealth SA ADR (MDXH)	2023	393,900%
SS Innovations International Inc Common Stock (SSII)	2022	126,150%
Applied Digital (APLD)	2021	11,073.33%
JIN MEDICAL INTERNATIONAL LTD Ordinary Shares (ZJYL)	2023	3,000.63%
Cipher Mining (CIFRW)	2023	2,206.67%
Destination XL (DXLG)	2021	2,067.94%
Soleno Therapeutics (SLNO)	2023	1,825.84%
Zivo Bioscience (ZIVO)	2021	1,788.16%
Lightwave Logic (LWLG)	2021	1,500%
Nine Energy Service (NINE)	2022	1,185.84%
AMC Entertainment (AMC)	2021	1,136.36%
Arqit Quantum Inc Warrants (ARQQW)	2021	1,060%
Carvana (CVNA)	2023	1,000.62%
LakeShore Biopharma (LSB)	2021	923.16%
Applied Opt (AAOI)	2023	895.88%
Aehr Test Systems (AEHR)	2021	867.2%
Myomo (MYO)	2023	854.29%
Pyxis Tankers (PXSAW)	2022	844.99%
Empire Petroleum (EP)	2021	814.42%
American Coastal Insurance (ACIC)	2023	767.82%
Greenwave Technology Solutions Inc Common Stock (GWAV)	2021	683.33%
GameStop (GME)	2021	681%
Neuropace (NPCE)	2023	647.1%